Literature DB >> 10913048

The direct effects of catecholamines on hepatic glucose production occur via alpha(1)- and beta(2)-receptors in the dog.

C A Chu1, D K Sindelar, K Igawa, S Sherck, D W Neal, M Emshwiller, A D Cherrington.   

Abstract

The role of alpha- and beta-adrenergic receptor subtypes in mediating the actions of catecholamines on hepatic glucose production (HGP) was determined in sixteen 18-h-fasted conscious dogs maintained on a pancreatic clamp with basal insulin and glucagon. The experiment consisted of a 100-min equilibration, a 40-min basal, and two 90-min test periods in groups 1 and 2, plus a 60-min third test period in groups 3 and 4. In group 1 [alpha-blockade with norepinephrine (alpha-blo+NE)], phentolamine (2 microg x kg(-1) x min(-1)) was infused portally during both test periods, and NE (50 ng x kg(-1) x min(-1)) was infused portally at the start of test period 2. In group 2, beta-blockade with epinephrine (beta-blo+EPI), propranolol (1 microg x kg(-1) x min(-1)) was infused portally during both test periods, and EPI (8 ng x kg(-1) x min(-1)) was infused portally during test period 2. In group 3 (alpha(1)-blo+NE), prazosin (4 microg x kg(-1) x min(-1)) was infused portally during all test periods, and NE (50 and 100 ng x kg(-1) x min(-1)) was infused portally during test periods 2 and 3, respectively. In group 4 (beta(2)-blo+EPI), butoxamine (40 microg x kg(-1) x min(-1)) was infused portally during all test periods, and EPI (8 and 40 ng x kg(-1) x min(-1)) was infused portally during test periods 2 and 3, respectively. In the presence of alpha- or alpha(1)-adrenergic blockade, a selective rise in hepatic sinusoidal NE failed to increase net hepatic glucose output (NHGO). In a previous study, the same rate of portal NE infusion had increased NHGO by 1.6 +/- 0.3 mg x kg(-1) x min(-1). In the presence of beta- or beta(2)-adrenergic blockade, the selective rise in hepatic sinusoidal EPI caused by EPI infusion at 8 ng x kg(-1) x min(-1) also failed to increase NHGO. In a previous study, the same rate of EPI infusion had increased NHGO by 1.6 +/- 0.4 mg x kg(-1) x min(-1). In conclusion, in the conscious dog, the direct effects of NE and EPI on HGP are predominantly mediated through alpha(1)- and beta(2)-adrenergic receptors, respectively.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10913048     DOI: 10.1152/ajpendo.2000.279.2.E463

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  12 in total

Review 1.  Metabolic effects of antihypertensive agents: role of sympathoadrenal and renin-angiotensin systems.

Authors:  Paul Ernsberger; Richard J Koletsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-06-17       Impact factor: 3.000

2.  Pulsatile changes in free fatty acids augment hepatic glucose production and preserves peripheral glucose homeostasis.

Authors:  Isabel R Hsu; Edward Zuniga; Richard N Bergman
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-04-27       Impact factor: 4.310

3.  Intra-islet glucagon signaling is critical for maintaining glucose homeostasis.

Authors:  Lu Zhu; Diptadip Dattaroy; Jonathan Pham; Lingdi Wang; Luiz F Barella; Yinghong Cui; Kenneth J Wilkins; Bryan L Roth; Ute Hochgeschwender; Franz M Matschinsky; Klaus H Kaestner; Nicolai M Doliba; Jürgen Wess
Journal:  JCI Insight       Date:  2019-04-23

4.  Glucose autoregulation is the dominant component of the hormone-independent counterregulatory response to hypoglycemia in the conscious dog.

Authors:  Justin M Gregory; Noelia Rivera; Guillaume Kraft; Jason J Winnick; Ben Farmer; Eric J Allen; E Patrick Donahue; Marta S Smith; Dale S Edgerton; Phillip E Williams; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-05-16       Impact factor: 4.310

5.  Greater systemic lipolysis in women compared with men during moderate-dose infusion of epinephrine and/or norepinephrine.

Authors:  Tracy J Horton; Suzanne Dow; Michael Armstrong; W Troy Donahoo
Journal:  J Appl Physiol (1985)       Date:  2009-04-30

6.  alpha2A-adrenoceptor antagonism increases insulin secretion and synergistically augments the insulinotropic effect of glibenclamide in mice.

Authors:  V Fagerholm; M Scheinin; M Haaparanta
Journal:  Br J Pharmacol       Date:  2008-05-19       Impact factor: 8.739

Review 7.  Metabolism, Metabolomics, and Nutritional Support of Patients with Sepsis.

Authors:  Joshua A Englert; Angela J Rogers
Journal:  Clin Chest Med       Date:  2016-03-12       Impact factor: 2.878

8.  Continuous Glucose Monitoring for Hypoglycemia Avoidance and Glucose Counterregulation in Long-Standing Type 1 Diabetes.

Authors:  Michael R Rickels; Amy J Peleckis; Cornelia Dalton-Bakes; Joseph R Naji; Nina A Ran; Huong-Lan Nguyen; Shannon O'Brien; Sanjian Chen; Insup Lee; Mark H Schutta
Journal:  J Clin Endocrinol Metab       Date:  2018-01-01       Impact factor: 5.958

Review 9.  Sepsis as a Pan-Endocrine Illness-Endocrine Disorders in Septic Patients.

Authors:  Weronika Wasyluk; Martyna Wasyluk; Agnieszka Zwolak
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.241

10.  Impaired hepatic counterregulatory response to insulin-induced hypoglycemia in hepatic denervated pigs.

Authors:  Michael Festersen Nielsen; Klaus Roelsgaard; Susanne Keiding; Kathrine Brodersen; Niels Møller; Mogens Vyberg; Hendrik Vilstrup
Journal:  J Clin Transl Endocrinol       Date:  2015-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.